Welcome to Target OIC for healthcare professionals

Welcome to Target OIC for healthcare professionals

Welcome to Target OIC for healthcare professionals

This site has been provided as a service to medicine by Kyowa Kirin, to provide information and resources for healthcare professionals involved with the treatment of opioid induced constipation (OIC). Target OIC does not contain any promotional information, however if you would like to find out more about a Kyowa Kirin medicine used to treat OIC, you can visit our promotional site here

Help to maximise your knowledge of opioid induced constipation (OIC) with our comprehensive yet easy to navigate eLearning. Work at your own pace, and test your knowledge at the end of each lesson to be awarded a certificate of completion

Find out more

Information about OIC, its impact on patients, diagnosis and pathophysiology, with quick links to diagnostic tools, including downloadable versions to print and use

Find out more

Visit the download centre to access helpful materials that can be downloaded for use in clinical practice, including diagnostic tools and patient leaflets, which have been designed in a printer friendly format

Take a look

References: 1. Bell T, Panchal S, Miaskowski C, et al. The prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European Patient Survey (PROBE 1). Pain Medicine. 2009;10(1):35-42. 2. Pappagallo M. Incidence, prevalence, and management of opioid bowel dysfunction. The American Journal of Surgery. 2001;182(5A Suppl):11S-18S. 3. Panchal S, Müller-Schwefe P, Wurzelmann J. Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden. International Journal of Clinical Practice. 2007;61(7):1181-1187.

References: 1. Bell T, Panchal S, Miaskowski C, et al. The prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European Patient Survey (PROBE 1). Pain Medicine. 2009;10(1):35-42. 2. Pappagallo M. Incidence, prevalence, and management of opioid bowel dysfunction. The American Journal of Surgery. 2001;182(5A Suppl):11S-18S. 3. Panchal S, Müller-Schwefe P, Wurzelmann J. Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden. International Journal of Clinical Practice. 2007;61(7):1181-1187.

KKI/UKIRE/MOV/0153 01/20     This website is intended for UK and IRE healthcare professionals and is provided as a service to medicine by Kyowa Kirin
KKI/UKIRE/MOV/0153 01/20 This website is intended for UK and IRE healthcare professionals and is provided as a service to medicine by Kyowa Kirin